ATP7A and neoplasm: To evaluate ATP7A’s role in glioma stemness in vivo, intracranial limiting dilution assays (10,000–100 cells) showed that ATP7A knockdown extended survival, indicating reduced tumor initiation (Supplemental Figure 10B).